Randox Sepsis innovation hailed by Health Secretary Matt Hancock
An innovative new tool for quickly diagnosing the often deadly infection Sepsis, will save lives, the Health Secretary has said.
The bedside test, being developed by healthcare diagnostics company Randox, will slash the 24 hours usually taken to identify the correct antibiotic for sepsis treatment. Currently, more than a third of those with sepsis die. Every hour that patients are not diagnosed increases the chance of death by 8%.
Health Secretary Matt Hancock said: “Instead of having to give people huge amounts of antibiotics across the board, which causes other problems, both medical and problems with resistance and super bugs, instead we will be able to work out exactly what the right treatment is for that individual person and do it fast enough to get the treatment in to save lives.”
He paid a visit to Randox’s new headquarters, the Randox Science Park, in Antrim, Northern Ireland on Thursday 21st March.
He added: “I can see a very clear application across the health service for how we can use the technology that is being developed here in Northern Ireland, both across the UK and indeed around the world.”
Sepsis can develop from infections caused by a simple cut or minor medical procedure. The body’s white blood cells fight the infection but the reaction can escalate and also damage healthy tissue.
Many who survive face amputations because of this tissue damage, Randox’s Molecular Diagnostics Manager Dr Martin Crockard said.
Dr Crockard highlighted that the traditional sepsis testing method, which involves sending blood samples to laboratories, takes too long. The problem is worsened by the fact that doctors are then forced to initially prescribe broad spectrum antibiotics which are not specific enough for individual patients. This encourages resistant strains.
To speed up the process, the new technology from Randox’s Biosciences division will allow clinicians in hospital emergency departments to check multiple samples simultaneously, at the press of a few buttons on a smart pad.
Dr Crockard said it is imperative that appropriate antibiotic treatment is administered as quickly as possible.
He said: “We can deal with the exact organism causing the problem in less than four hours, allowing you to tailor the treatment for that individual patient very quickly.”
The UK Sepsis Trust’s Chief Executive Ron Daniels said: “Randox is leading the way around molecular technologies.
“No other system brings this so close to the clinician on the shop floor.”
For further information please contact the Randox PR team by emailing firstname.lastname@example.org or phoning 028 9442 2413
A £700,000 UK Research and Innovation investment into manufacturing processes at Randox means patients could benefit from quicker, cheaper and more consistent diagnosis of diseases.
The announcement comes exactly one year after the government launched its modern Industrial Strategy – the long-term plan to boost productivity by backing businesses to create high-quality, well-paid jobs in every corner of the United Kingdom.
The Industrial Strategy Challenge Fund (ISCF) award, administered by UK Research and Innovation (UKRI), will allow Randox Laboratories to further develop its state-of-the-art ‘freeze-drying’ technology which enables the components of vital diagnostic kits to be manufactured, stored and transported more effectively, producing better and speedier diagnoses.
For the first time it also allows this complicated manufacturing process to be carried out in the UK rather than having to be outsourced to countries such as the United States, bringing more jobs and economic growth. These new genomic analysis tools also have the potential to make a major impact in the global fight against antimicrobial resistance by identifying and quickly sharing information about resistant microbial strains.
More in-depth analysis of biomarkers in blood and other bodily fluid levels will allow better, quicker diagnosis of cancers and a range of other diseases, ranging from respiratory infections to sepsis, such as blood poisoning.
The Secretary of State for Northern Ireland said:
“I am delighted to announce a £700,000k UK Government investment in Randox, a multinational life sciences company in County Antrim. This funding will bring significant benefits to Randox’s vital medical diagnostics and help create well-paid manufacturing jobs in Northern Ireland.
“A year-on from the launch of our Modern Industrial Strategy, this investment highlights the great progress we are making to boost productivity by backing leading businesses and creating high-quality jobs in every corner of the United Kingdom.”
John Penrose, Minister of State for Northern Ireland, who visited Randox today to mark the new investment, said:
“Everyone always says the UK needs more high-tec, high-value added manufacturing and the high-skilled, high-waged jobs it brings. But Randox are actually doing it right here in Northern Ireland. This is properly world leading, cutting-edge industry and I’m delighted that today’s money is helping bring the vision to life.”
Dr Peter FitzGerald, Managing Director of Randox Laboratories, commented:
“Innovative diagnostic technologies are not only capable of diagnosing disease and ill-health at the earliest possible stage, but they also have a real potential to advance personalised medicine. Our commitment to developing new and exciting breakthroughs in science, technology, engineering and manufacturing is therefore matched only, by our passion to transform the life of the patient. Randox is leading the way in moving from a one-size-fits-all approach towards decisions, practices, and products tailored to the needs of the individual and the Industrial Strategy Challenge Fund award brings us one step closer to realising that aim.”
Funded through UK Research and Innovation, the award forms part of the ISCF Early Diagnosis and Precision Medicine programme, focusing on the use of diagnostic information and genetic analysis to drive more personalised healthcare. Innovate UK, now part of UK Research and Innovation, has supported Randox extensively since 2010, helping grow and scale an innovative diagnostics company who are now distributing their products all over the world.
The announcement comes after the government’s announcement of the Life Sciences Sector Deal that will support healthcare innovation and back businesses to create high-paid, high-quality jobs as part of the government’s modern Industrial Strategy. The deal signals a vote in confidence in UK industry, with global biopharmaceutical company UCB investing around £1 billion in research and development.
For further information please contact Randox PR by emailing email@example.com
Have you heard about our IT Open Evening on Tuesday 20th November? We’re offering those interested in Software Development, Information Security, Web Design and IT Support the opportunity to have a look around our state-of-the-art IT facilities at the Randox Science Park.
But as a company known throughout the world for its high-quality health diagnostic products, you may have been surprised to hear that we have such wide-ranging roles available in Information Technology.
“Randox? Isn’t that just for scientists?” we hear you say.
We turned to Randox IT Software Developer Scott McPeake for the answer. This is what he said.
“I imagine if you were to ask my friends from my Computer Science course at university, if they previously knew that Randox offers jobs in IT, they would say no.
But really, it’s not surprising when you think about it. Technology underpins everything we do in life. Everything is moving digital, and everything digital involves software in some shape or form.
Even jobs which you assume are predominantly tech-free – let’s say for example, a bus driver – use technology every day. A bus driver relies on technology to administer tickets and to plan their travel routes. It truly is everywhere and it’s only going to expand more.
Without an innovative IT department, Randox wouldn’t be the successful and reputable company it is today. If there was no IT team, there would be no lab equipment, no websites, no apps. Even organisations who don’t specialise in IT still have it as a core function of the company.
In the Software Development team, in particular, we design and develop the software used in laboratories to compare results from instruments and samples against other laboratories, to see how these results compare.
It’s important work, as all our scientists rely on us to be able to do their work in providing blood test results to patients across the world. Our software needs to be operating perfectly to ensure people are getting the correct results and therefore the correct diagnosis. And that’s what makes Randox so reputable.
Access to technologies
Being part of a company that is so well established and successful also means that we get exposed to the latest innovations. With IT influencing so much of what we do here, we’re at the forefront of all projects and developments, and are given access to the most up-to-date technologies to make sure we’re providing the best possible products and user experience for our customers, and can stay head of our competitors.
We’re able therefore to bring to management our ideas about what new software we would like to try, to suggest how it would improve our work. So new software is coming in all the time. I’m currently working with MVC architecture which is a key software framework used widely across the world. It’s definitely something good to get experience in, as is typescript, which although not used as much, is really interesting, and I’ve certainly enjoyed the opportunity to try something new.
And of course, working in Randox, we also get the opportunity to learn about the science of diagnostics, and in particular the machines on which we’re implementing our software designs, which carry out blood testing in hospitals and laboratories. It’s good to challenge yourself to learn something new.
Teamwork and collaboration
The chance to expand your knowledge and improve your skills repertoire is probably one of my favourite things about working here at Randox. Everyone works really collaboratively and we help each other out when we need it. So if you don’t know something, no one is going to chastise you. Asking for help and advice is actively encouraged because we each have our own strengths and weaknesses and we can help each other to be a better team. Everyone in the Randox IT team is really willing to help and makes time for you if you need it.
I remember on my first day here I was really nervous and I arrived at the door unable to get in because it was locked. Someone in the team immediately came to the door, asked me if I was new and welcomed me in to the building. That instantly set the tone. Everyone was really welcoming, friendly and professional.
And this ability to work together is so crucial. Most days we will be working on the same site but perhaps on different pages so we have to talk to each other to make sure my page doesn’t break theirs and vice versa. Quite often we’ll design the layout of the software collaboratively, and most days we’ll have a morning meeting to discuss our progress.
If we’re creating something new, we’ll draw up the design based on user requirements and create the software to those designs. Or if an existing site doesn’t work properly, we’ll write up the problem, how to solve it, and then push it up to the production server to fix the bugs.
So communication is fundamental, as is problem solving. Being able to keep calm under pressure is also an inherent skill for programming. Deadlines happen; they’re a real thing. You can’t take all day to do something. But it keeps things challenging for us, which is vital, as you don’t want to put your brain to sleep. The work is challenging but solvable, and as I said, you have the team there to help you out and support you.
We all get on really well and the more experienced software developers in the team have been such great mentors to me. If you’re interested in working in IT I would certainly recommend coming along to our IT Open Evening on Tuesday 20th November so that you can meet all of us and have the opportunity to take a tour of our brand-new facilities in the Randox Science Park.
Working in Antrim
The site is really spacious, modern, and easy to get to. For me, coming from Coleraine, I’m just able to get the train to the Antrim station, which is right beside the bus station aswell.
And Antrim has everything you could need. Shops, supermarkets, nice affordable places to live, and plenty of cafés and restaurants. Sometimes we’ll head out as a team in to Antrim for lunch or dinner together, or if we fancy Belfast, it’s just a short journey on the train.
So if you’re interested in a dynamic career in software development, take the trip to Antrim to find out a bit more about what Randox has to offer during our Open Evening on 20th November.
You might not have thought of Randox as a software house but we’re here and we’re working hard to improve healthcare globally!”
To attend the Randox IT Open Evening on Tuesday 20th November, register for tickets on EventBrite by clicking here.
For further information please contact the Randox PR team by emailing firstname.lastname@example.org or phoning 028 9442 2413
Healthcare diagnostics company Randox has today announced 25 new specialist IT roles ranging from Software Development and Information Security to Web Design and IT Support.
The roles, which will span a variety of career pathways, including placements, graduates, apprenticeships and permanent positions, will be based at the firm’s new headquarters, the Randox Science Park in Antrim, which will host an IT Open Evening on Tuesday 20th November.
Those in attendance at the Open Evening will be invited to enjoy a tour of the Randox Science Park, which, following purchase by Randox in 2015, is being developed into a manufacturing and research facility in an investment totalling £161m. The ongoing renovation plans, when complete, will have created a total of 540 high value job opportunities at the site, with an average salary of £30k per year that will generate £16.2 million in annual salaries.
Stephen Fawl, Randox IT Manager, commented;
“Working at the cutting edge of technology and innovation, the Randox IT department design and develop a range of web-based applications and software, support the tech infrastructure of more than 1400 employees worldwide, and implement the very latest in security protocols. It’s no surprise therefore that we’re seeking the very best talent to join our team – offering competitive salaries, career progression, personal development and the opportunity to work in an incredibly forward-thinking company. We invite anybody who is interested in a dynamic career in IT to visit us from 6-8pm on the 20th November for our Open Evening at the Randox Science Park.”
Dr Peter FitzGerald, Managing Director of Randox Laboratories, added;
“As a global leader in healthcare diagnostics, we must continue innovating, through our people, through our world-class R&D, and through our infrastructure. With technology heavily influencing so much of what we do, the Randox IT department remain at the forefront of our capability and have a critical role to play in the delivery of cutting-edge innovation. The newly-refurbished IT facilities at the Randox Science Park in Antrim give the team there the platform to engage across a broad range of projects, to make a real and important impact upon global healthcare.”
Randox, renowned for the placement and employment opportunities it provides students and graduates at both Queen’s University Belfast and Ulster University, has recently launched an ‘Earn As Your Learn’ Higher Level Apprenticeship in Computing, with Northern Regional College.
Through the ‘Career Encode’ programme, Randox is offering three-year apprenticeship vacancies in the IT department, in addition to a range of senior roles for the more experienced IT professional. The apprenticeship scheme is equivalent to a foundation degree and provides a clear progression route for apprentices to train to the highest level whilst gaining a professional qualification.
Councillor Paul Michael, Mayor of Antrim and Newtownabbey, commented;
“The creation of these specialist IT jobs for the Antrim community, as a direct result of Randox’s ongoing investment and expansion is further proof, if needed, of their commitment to the regional economy. To be able to offer both experienced and aspiring IT professionals, whether students, graduates or full-time IT specialists, the opportunity to work in such high-calibre roles so close to home is an incredibly unique opportunity and I look forward to welcoming new IT staff to the fantastic Randox Science Park facilities.”
Randox Laboratories currently employ 1400 employees globally, 800 of which are based in its Northern Ireland sites in Crumlin and Antrim.
Register your interest for the Randox IT Open Evening by collecting your free tickets here.
For further information about the Randox IT Open Evening, please contact Randox PR by emailing email@example.com or phoning 028 9442 2413.
Randox IT Manager Stephen Fawl and Senior Recruitment Consultant Lyndsay Rodgerson are pictured with Councillor Paul Michael, Mayor of Antrim and Newtownabbey, at the launch of Randox’s 25 new specialist IT roles
A record £50 million investment which will deliver cutting-edge technologies to diagnose conditions like cancer, heart conditions and infectious diseases has been announced by Northern Ireland diagnostics company Randox Laboratories and Invest Northern Ireland.
This major project involves the establishment of three Centres of Excellence, enabling Randox R&D scientists to work collaboratively with colleagues from Queen’s University Belfast and Ulster University. The centres are being officially launched today at the Randox Science Park. The ceremony will include a keynote address from Sir John Bell, who chaired the UK Government’s Life Sciences Industrial Strategy Board.
Advanced diagnostics have been identified as key to delivering sustainable improvement to healthcare systems struggling to cope with increasing levels of chronic and preventable conditions. Having been focused in this field for over 36 years, Randox has a successful track record of developing new and innovative tests – examples include assessing those at risk of Alzheimer’s disease and genetic cardiac conditions, to promote and enable preventive treatment, and a new clinically-approved test to diagnose prediabetes.
Managing Director of Randox Laboratories, Dr Peter FitzGerald, who today launched the three Centres of Excellence, said;
“When almost a quarter of the deaths of people under 75 in the UK are considered preventable, we need to ask ourselves what can be done to improve healthcare outcomes. There is an undeniable case for radical change in the way healthcare is delivered, and sophisticated diagnostics will be at the fore of this revolution.
“Enabling earlier and more accurate diagnosis, to identify those at the earliest stages of illness, ideally before the onset of any symptoms, is a game-changer. Through early intervention we can restrict the development of chronic conditions and improve people’s lives. Our view of the future is one where people are empowered through earlier diagnosis to stay healthier for longer, and where healthcare systems are freed to deliver quality services to patients. Our announcement today demonstrates our continuing commitment in this field.
“We are grateful for the support offered by Invest NI and look forward to addressing these pressing healthcare needs.”
The Centres of Excellence will focus respectively on clinical diagnostics, engineering for biosciences and quality control. The project, which will strengthen collaborative partnerships between Randox, Queen’s University Belfast and Ulster University, will accelerate the development of new technologies and drive healthcare improvements regionally, nationally and across the globe.
Of the £23m of support offered by Invest NI, £5m will go toward research projects at Ulster University and Queen’s University Belfast.
Welcoming the investment, Alastair Hamilton, Chief Executive of Invest NI said;
“Randox has a long history of investing heavily in innovation and R&D which has enabled it to create a globally competitive export driven business, capable of developing world leading research. This major investment will enable Randox to perform cutting-edge R&D which has the potential to revolutionise the global healthcare industry. This is excellent news for Northern Ireland’s life and health sciences sector. Northern Ireland is enjoying a growing international reputation as a region of expertise and knowledge in key areas such as Diagnostics, Precision Medicine and Advanced Manufacturing. The three new Centres of Excellence will help build on this and enhance Northern Ireland’s credibility, provide supply chain opportunities, and encourage knowledge transfer with our universities.”
Sir John Bell, commenting on the potential for the UK Life Sciences sector said;
“The life sciences industry represents one of the dominant economic sectors in the UK, and one with considerable potential for growth. However, whilst we have many natural strengths we cannot afford to be complacent. We must strive to optimise our science base, to encourage collaboration across academia, industry and the NHS, and grow our industrial capabilities. To do so we need to use our extensive data sets to best effect, and have in place a strong skills strategy. Success requires vision and drive. To that end I would like to congratulate Dr FitzGerald and Randox in the establishment of these three R&D collaborative Centres of Excellence – these are assets of national standing and will have a meaningful impact in enabling earlier and more accurate diagnosis, driving improvements in patient care, regionally, nationally and globally. They are leaders in this field, committed to innovation, and I wish them every success.”
Professor Jim McLaughlin, Director of Ulster University’s Nanotechnology and Integrated Bioengineering Centre, added;
“This very welcome investment enables pioneering Randox-inspired engineering capacity at Ulster University and reflects our research commitment to the life sciences industry. From nanotechnology to the development of systems that will enable large scale laboratory capability to be produced in the palm of your hand, the partnership brings shared industry and academic research excellence from the lab into the marketplace. Life sciences is a vital economic sector locally and this collaboration will advance diagnostics and ultimately enhance patient health outcomes.”
Dr David Jess, Senior Lecturer at Queen’s University Belfast School of Mathematics and Physics, added;
“The Randox Centres of Excellence will allow Queen’s University Belfast to continue to deliver cutting-edge and world leading research. We look forward to collaborating further with industry to develop pioneering research, focused on the needs of society.”
Invest NI’s R&D support is part funded by ERDF under the EU Investment for Growth and Jobs Programme 2014 – 2020.
For further information please contact the Randox PR Team: phone 028 9442 2413 or email firstname.lastname@example.org
On Wednesday 15th November, Randox hosted a site visit at its state-of-the-art Randox Science Park in Antrim for Open University (OU) students who are studying a range of subjects including Business, Science, Engineering and Software Development.
Randox is a global leader in healthcare diagnostics, pioneering innovative technologies with major focus in research and development. Their products and services are used in hospitals, clinical, research and molecular laboratories, food testing, forensic toxicology, life sciences, and veterinary laboratories worldwide.
The visit allowed the students the opportunity to experience real life lab experiments in the Research and Development department and the Design Engineering department. They also had the opportunity to tour the different IT departments and see how the operations of a large company work.
Sarah Nicol who is studying for a BSc (Honours) in Computing and IT said:
“It was interesting to hear about the full scope of work taking place within the Randox Science Park and the level of investment confirms that there is a bright future here as an employee. The training and opportunities available were much wider than I had realised.”
Joanne King who is studying for a BSc (Honours) in Health Sciences said:
“I found the visit interesting and informative. I enjoyed meeting and hearing from the current Open University students and what they were getting involved with during their placements at Randox. I certainly found the experience motivating to complete my course as opportunities may be possible with Randox.”
The students were then able to hear from two OU students who are currently on a placement with Randox: Jenny Hope who is studying BSc (Hons) in Health Sciences and Aurelija Gainaite who is studying BSc (Hons) in Natural Sciences. They are both on a one-year placement with Randox and shared with the students the importance of gaining relevant work experience in a chosen field and the potential opportunities it can lead to.
Jolene Carey, Human Resource Officer from Randox said:
“We were delighted to host The Open University students at Randox – this was a great opportunity for students to gain a valuable insight into the range of different departments within the company and to experience how they work together. We were delighted that OU students Jenny and Aurelija were able to talk directly to their fellow students and explain the benefits of gaining a placement opportunity. We look forward to continuing to develop our relationship with The Open University.”
For further information, please contact our Randox PR team by emailing email@example.com or by phoning 028 9442 2413
St. John Ambulance and global healthcare diagnostics company Randox have today announced an innovative new partnership to enhance the services provided by the first aid organisation in the Antrim area.
In addition to the new labs, offices and manufacturing space which have so far been installed at the former Massereene Barracks, St. John Ambulance will also now form part of the Randox’s Science Park renovation plans.
Dr Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“It is particularly fitting that we are now working with St. John Ambulance, given that both of our organisations are built upon a commitment to improve health and wellbeing. We’re delighted to be able to offer space for the organisation’s fleet of ambulances, and look forward to working closely with them as we enter the next phase of our Randox Science Park renovation plans.”
As part of the partnership between Randox and St. John Ambulance, St. John’s will be offering first aid training to staff within the healthcare diagnostics firm through its corporate training team.
On moving the Antrim fleet of St. John Ambulances to the Randox Science Park, Alan McClean, Unit Leader for St. John Ambulance Antrim division, said;
“Working with an organisation as reputable as Randox, from a location as central within Antrim as the Randox Science Park, will not only ensure prompt emergency response times, but will also enhance the services we offer. We want everyone in Northern Ireland to be first aid trained and to be able to receive first aid from those around them. Moving our Antrim fleet of ambulances to the Randox Science Park brings us one step closer to delivering on that aim.”
For further information, please contact our Randox PR team by emailing firstname.lastname@example.org or by phoning 028 9442 2413
Following the success of the first ever Randox Health Grand National, global health diagnostics company Randox has today announced the official opening of its new central laboratory, Randox Clinical Laboratory Services (RCLS), at the recently acquired Randox Science Park in Antrim, Northern Ireland.
Situated at this new state of the art biohub, the RCLS accredited lab now houses Randox’s latest blood screening equipment – the pioneering Evolution machine. This new technology enables the labs to conduct a full range of niche and standard research testing, as well as current health testing for the company’s Randox Health division, which offers the world’s most comprehensive full body health analysis.
Research areas at the newly accredited laboratory include but are not exclusive to cancer, fertility, heart, inflammation, stroke and kidney health, both in-house and collaboratively with external organisations. Current and past collaborations include an Acute Kidney Injury Study with the Royal Victoria Hospital, a Bladder Cancer Study in partnership with Queen’s University Belfast and The Belfast Trust, a Stroke and Brain Injury study with Cambridge University, and key partnerships with a number of major pharmaceutical companies.
A staggering 222 clinical diagnostic tests are currently run routinely with the lab, with more tests pending accreditation in the coming months.
Ann-Marie Jennings, Laboratory Manager for Randox Clinical Laboratory Services, explained that the new facilities will allow RCLS to increase their output and enter new markets;
“Randox Clinical Laboratory Services has been operational for a number of years in our headquarters in Crumlin, near the Belfast International Airport. Now that we have moved to our new, purpose-built labs in the Randox Science Park, we have the ability to increase the output of both our health testing and our research testing. This involves expanding our team of experienced scientists, working towards further accreditations and furthermore setting up independent labs in Dubai, LA, Holywood and Liverpool in addition to our current labs in Antrim and London.”
Thanks to the new Randox Science Park facilities, the company will now be able to provide an increasingly wide range of testing services to Biotechnology and In Vitro Diagnostic companies, and will deliver to pharmaceutical companies the testing services required to support their drug development projects, in addition to the testing provided to research organisations,
With the ability to conduct an unrivalled range of health testing – haematology, biochemistry and immunoassay – all under one roof, the laboratory offers unparalleled support services to the dynamic and growing healthcare industry. With a greater understanding of human complexity, pharmaceutical companies are now focusing on developing safer drugs tailored to specific patient groups or sub-groups and the expansion plans in motion at RCLS will help these organisations bring new drugs to market faster.
“On our patented Randox Biochip Array Technology we can customize bespoke testing platforms based on the requirements of each drug development project, which can be a challenging process. From initial product development to clinical trial stages there can be a number of barriers and time constraints before drugs are successfully released to the public. We’re confident that our newly enhanced capabilities will benefit patients suffering from conditions in most need of research by offering pharmaceutical companies at the forefront of pioneering research, with the latest technological developments.”
For more information about RCLS please contact Randox PR on 028 9442 2413 or email RandoxPR@randox.com
On Monday 21st November, Secretary of State for Northern Ireland, Rt Hon James Brokenshire MP, visited our new Randox Science Park facility.
The visit was part of the Mr Brokenshire’s recently established Business Advisory Group sectoral meetings, of which the Life Science sector is a key stakeholder.
Following the visit, the Secretary of State said:
“I was absolutely delighted to visit the very impressive facilities at the Randox Science Park, in what used to be Massereene Barracks. During my tour of the site, I was struck by the powerful symbolism of what used to be the defence estate of the old Northern Ireland to what has now been transformed into world class laboratories and life sciences facilities. This showcases Northern Ireland as a leading contributor in the world of knowledge economy, and this is an area which I am confident will continue to grow.
“My visit here is to help re-affirm the Government’s commitment to do whatever is needed to safeguard the economy and forge a new global role for ourselves as we leave the European Union. The UK Government remains committed to making this country the best place in Europe to own and grow a business and to building a stronger economy that works for everyone.”
Dr Peter FitzGerald, Managing Director of Randox, said:
“We were delighted to welcome the Rt Hon James Brokenshire MP to our new Randox Science Park in Antrim, and we are encouraged by the Government’s support for the creation of a positive business environment. Since 1982 we have championed Northern Ireland and the very talented people who work with us. Our commitment to a positive future is perfectly illustrated by the evolution of this site from former army barracks to state-of-the-art biotechnology hub.
“As an innovation-led company, these revolutionary facilities are fundamental to enable us to develop more accurate and sensitive diagnostic capabilities and promote preventive healthcare globally. It will also contribute significantly to supporting the Northern Ireland economy with the creation of new jobs and increased exports. This is a significant investment, which markets not only a dynamic Randox to the world but also a positive Northern Ireland.”
For more information about the Secretary of State’s visit to the Randox Science Park please contact our PR team via email: email@example.com
The future of diagnostic healthcare has been unveiled at the Randox Science Park in Antrim, as the company’s annual global distributors’ conference gets underway. Delegates from more than 90 countries are taking part in the world-leading healthcare firm’s three-day event at the Hilton Hotel in Templepatrick.
As well as discussions about developments in reagents and quality control products, participants enjoyed demonstrations of Randox’s patented Biochip Array Technology and its extensive range of analysers from the RX Series.
Melansha Fernando from Alpha and Omega Diagnostics in Sri Lanka said,
“Randox has released so many new products recently that laboratories in my country are increasingly interested in what it can offer. As a result I felt it important to come here to learn more about the new technologies. The truly global nature of the company has been impressed upon me after meeting colleagues from so many different countries – I’m delighted to have been able to take part.”
Speaking at the conference, Dr. Peter Fitzgerald said,
“All exporters are aware of the considerable challenges we must overcome in order to do business in the global market but year on year our teams across the world have helped to drive our success. One of the biggest challenges Randox faces is the one we put to ourselves, to deliver truly transformative technologies and improve health worldwide. We recently celebrated our £1 billionth sale and we now look to build on that achievement and accelerate our rate of growth. All of our profits go straight to either R&D, or the development of our infrastructure, so strong growth is key to our goal of revolutionising diagnostics and saving lives across the world.”
Susan Hammond, Global Reagents Sales Manager said,
“It is a pleasure to see the diversity of our distributors gathered together in one room, and recognize how far we have come as an international company. We dedicated Thursday to focusing on building relationships with our worldwide distributors to ensure that they attain the best product knowledge available. Over 100,000 end users employ Randox products and every second of every day 80 Randox tests are used across the world, and it is vital our distributors are kept up to date with every new development.”
For more information on the Distributors’ Conference contact Amy in our PR Team by calling 028 9445 1016 or email firstname.lastname@example.org